Early low blood MALT1 expression levels forecast better efficacy of PD‑1 inhibitor‑based treatment in patients with metastatic colorectal cancer

Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) modulates colorectal cancer (CRC) malignant behaviors and tumor immune escape. The present study aimed to explore the association of MALT1 with treatment response and survival time among patients with metastatic CRC (mCRC) af...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chuanming, Yu, Fan, Xu, Wanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320427/
https://www.ncbi.nlm.nih.gov/pubmed/37415633
http://dx.doi.org/10.3892/ol.2023.13915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320427/
https://www.ncbi.nlm.nih.gov/pubmed/37415633
http://dx.doi.org/10.3892/ol.2023.13915

Ejemplares similares